Skip to main content

Table 1 Characteristics of study population by HAART status at Burayu Health center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Variable HAART initiated (n=126) Non-HAART (n=126)
N (%) N (%)
Gender Female 86(68.3) 96(76.2)
Male 40(31.7) 30(23.8)
Age group (years) Mean ± SD 37.1(9.8) 33.4(10.2)
18-29 25(19.8) 51(40.5)**
30-39 61(48.4) 49(38.9)
40-49 25(19.8) 16(12.7)
≥50 15(11.9) 10(7.9)
BMI Mean ± SD 21.9(3.2) 20.8(2.8)
<18.5 9(7.1) 24(19)*
18.5-24.9 97(77) 91(72.2)
25-29.9 17(13.5) 10(7.9)
≥30 3(2.4) 1(0.8)
CD4+ cells (cells/mm3) Mean ± SD 314.5 ± 152.5 413.6 ± 246.2
<200 34(27) 25(19.8)**
200-400 58(46) 42(33.3)
>400 34(27) 59(46.8)
Duration of HIV infection (month) Mean ± SD 29.5(17) 11.8(12.3)
<6 0(0) 57(45.2)***
6-12 22(17.5) 21(16.7)
13-24 22(17.5) 27(21.4)
25-41 59(46.8) 19(15.1)
≥42 23(18.3) 2(1.6)
TB Co-infection Present 21(16.7) 18(14.3)
Not present 105(83.3) 108(85.7)
  1. N, number; BMI, body mass index; HAART, highly active antiretroviral therapy; TB, tuberculosis; SD, standard deviation; *p-value =0.02; **p-value =0.004; ***p-value <0.0001.